Tooploox vs Opinov8: full comparison for 2026
Quick verdict
Tooploox (4.3/5) edges ahead of Opinov8 (4.2/5) overall. Tooploox is the better choice for hard ML/AI research-engineering problems. Opinov8 is the stronger option for enterprises and startups, AI across cloud engineering. The right choice depends on your project size, budget, and required tech stack.
Tooploox vs Opinov8: head-to-head summary
| Criterion | Tooploox | Opinov8 |
|---|---|---|
| Founded | 2012 | 2017 |
| HQ | Wroclaw, Poland | London, UK |
| Team size | 51–200 | 201–500 |
| Rating | 4.3 / 5 | 4.2 / 5 |
| Primary differentiator | Research-grade ML engineering with peer-reviewed academic recognition at ECCV 2024, alongside client delivery | AI treated as a foundational layer across the entire engineering lifecycle, not a bolt-on service |
| Pricing model | Fixed project, dedicated team | Fixed project, dedicated team, staff augmentation |
| Min. engagement | $25K | $30K |
| Primary tech stack | Python, PyTorch, TensorFlow | Python, AWS, Azure |
| Industries served | Healthcare, Enterprise, Media, SaaS | Fintech, Enterprise, Healthcare, Retail |
Tooploox vs Opinov8: overview
Tooploox
Tooploox, founded in 2012 and based in Wroclaw and Warsaw, Poland, is an engineering company that specifically takes on projects where AI and machine learning represent the core technical challenge, rather than treating ML as a secondary feature. Its portfolio includes a digital histopathology platform and a neural network technique (MagMax) recognized at ECCV 2024. Tooploox was named Top AI Company in Poland and Top Machine Learning Company in Poland for 2025 by Clutch.
Opinov8
Opinov8 Digital and Engineering Solutions is a London, UK-headquartered firm founded in 2017, with 200 to 300 professionals across Europe, the Americas, and MENA. Opinov8 blends software engineering, cloud, data, and AI expertise, positioning AI as a foundation of its delivery process rather than an add-on feature. The company was honored as Best AI Company in Europe by The Netty Awards, per company website; independently unverifiable.
Services and capabilities: Tooploox vs Opinov8
| Capability | Tooploox | Opinov8 |
|---|---|---|
| ML model development | ✓ | ✓ |
| Computer vision | ✓ | ✗ |
| NLP | ✗ | ✗ |
| Generative AI / LLM integration | ✗ | ✗ |
| MLOps | ✗ | ✓ |
| AI strategy consulting | ✓ | ✓ |
| Staff augmentation | ✗ | ✗ |
Tech stack comparison: Tooploox vs Opinov8
| Framework / platform | Tooploox | Opinov8 |
|---|---|---|
| Python | ✓ | ✓ |
| TensorFlow | ✓ | ✓ |
| PyTorch | ✓ | ✓ |
| AWS | ✓ | ✓ |
| Azure | N/A | ✓ |
| Kubernetes | ✓ | ✓ |
Pricing comparison: Tooploox vs Opinov8
| Criterion | Tooploox | Opinov8 |
|---|---|---|
| Minimum engagement | $25K | $30K |
| Engagement models | Fixed project, Dedicated team | Fixed project, Dedicated team, Staff augmentation |
| Rate transparency | Minimum disclosed | Minimum disclosed |
| Price tier | Accessible | Accessible |
Target audience comparison: Tooploox vs Opinov8
| Dimension | Tooploox | Opinov8 |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Healthcare, Enterprise, Media | Fintech, Enterprise, Healthcare |
| Best use cases | Digital histopathology and medical imaging analysis, Novel neural network architecture research and development | Embedding ML capabilities into an existing enterprise cloud platform, AI-augmented software modernization programmes |
| Typical project type | Fixed project | Fixed project |
Tooploox vs Opinov8: pros and cons
| Tooploox | |
|---|---|
| + | Recognized by Clutch as Top AI Company and Top Machine Learning Company in Poland for 2025 |
| + | Academic-grade research credibility, including a technique presented at ECCV 2024 |
| + | Over a decade of operating history since founding in 2012, focused specifically on hard ML problems |
| + | Domain depth in digital histopathology and healthcare computer vision |
| - | Research-oriented positioning may mean higher cost for simpler, more standard ML integration work |
| - | Mid-size team (51–200) shared across research and delivery work |
| Opinov8 | |
|---|---|
| + | 200 to 300 person team spans multiple regions, including Europe, the Americas, and MENA, for global coverage |
| + | AI integrated into a broader cloud and software engineering practice, useful for full-stack programmes |
| + | Industry recognition including a Netty Award for Best AI Company in Europe, per company website |
| + | Founded in 2017 with steady growth into a mid-size, multi-region firm |
| - | Broader cloud and software engineering scope means ML is one service line among several |
| - | Award recognition is self-reported by the company and not independently verifiable |
| - | Higher minimum engagement size than boutique ML-only specialists |
Who should choose Tooploox?
A typical fit: digital histopathology and medical imaging analysis.
Research-grade ML engineering with peer-reviewed academic recognition at ECCV 2024, alongside client delivery. Minimum engagement starts at $25K. Works best with clients in Healthcare, Enterprise, Media, SaaS.
Who should choose Opinov8?
A typical fit: embedding ML capabilities into an existing enterprise cloud platform.
AI treated as a foundational layer across the entire engineering lifecycle, not a bolt-on service. Minimum engagement starts at $30K. Works best with clients in Fintech, Enterprise, Healthcare, Retail.
Decision matrix: Tooploox vs Opinov8
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Tooploox |
| You need a large dedicated team for an ongoing programme | Tooploox |
| Your budget is at the lower end | Tooploox |
| You need specialist depth in a specific vertical | Tooploox |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Tooploox |
Use case fit: Tooploox vs Opinov8
| Use case | Tooploox fit | Opinov8 fit | Winner |
|---|---|---|---|
| Digital histopathology and medical imaging analysis | Strong | Limited | Tooploox |
| Novel neural network architecture research and development | Strong | Limited | Tooploox |
| Embedding ML capabilities into an existing enterprise cloud platform | Limited | Strong | Opinov8 |
| AI-augmented software modernization programmes | Limited | Strong | Opinov8 |
| Fixed-price build | Limited | Limited | Both equally |
| Staff augmentation | Limited | Limited | Both equally |
Verdict: Tooploox vs Opinov8
Tooploox (4.3/5) is the stronger overall choice for most Machine Learning Development projects. Research-grade ML engineering with peer-reviewed academic recognition at ECCV 2024, alongside client delivery.
Opinov8 (4.2/5) is worth a look if you need AI-augmented software modernization programmes. If your situation matches that, Opinov8 is a competitive option.
Related comparisons
Tooploox vs Opinov8 FAQ
Is Tooploox better than Opinov8?
Tooploox (4.3/5) scores higher overall, but "better" depends on your use case. Tooploox's strongest advantage: recognized by Clutch as Top AI Company and Top Machine Learning Company in Poland for 2025. Opinov8's strongest advantage: 200 to 300 person team spans multiple regions, including Europe, the Americas, and MENA, for global coverage.
How do Tooploox and Opinov8 differ in pricing?
Tooploox uses fixed project, dedicated team pricing with a minimum engagement of $25K. Opinov8 uses fixed project, dedicated team, staff augmentation pricing with a minimum engagement of $30K. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Tooploox or Opinov8?
Opinov8 is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Tooploox and Opinov8?
Tooploox's primary differentiator is: research-grade ML engineering with peer-reviewed academic recognition at ECCV 2024, alongside client delivery. Opinov8's primary differentiator is: AI treated as a foundational layer across the entire engineering lifecycle, not a bolt-on service. They also differ in team size (51–200 vs 201–500), minimum engagement ($25K vs $30K), and primary industries served (Healthcare, Enterprise vs Fintech, Enterprise).